The hypermetabolic state observed post-exertion in ME/CFS patients, as described by Germain et al
Some of the medications that may be used include: GLP-1 Agonists: semaglutide, tirzepatide, liraglutide, or dulaglutide Phentermine Topiramate Metformin Bupropion Naltrexone Vyvanse (for binge eating disorder) Your Wellness Journey Starts Here Our medical weight loss program is your pathway to a healthier, more vibrant life
Individual results vary based on dose, adherence, diet, activity, and baseline health
Consistent with our structure-based predictions, most of these mutants were deficient in IGF1-dependent activation (Fig
Instead, they advise patients who develop NAION to engage in shared decision making with their providers about whether to discontinue the drug based on individual risks
For a medication class with documented neuropsychiatric monitoring guidance, this placement is hard to defend